Raloxifene Powder is approved for the prevention and treatment of
osteoporosis in postmenopausal women. It is in a class of drugs called
estrogen agonists/antagonists that have been developed to provide the
beneficial effects of estrogens without all of the potential
disadvantages. It is neither an estrogen nor a hormone. Raloxifene is
sometimes called a selective estrogen receptor modulator (SERM).
wisepoqder β-agonist Powder
Raloxifene reduces the risk of spine fractures. There are no data
showing that raloxifene reduces the risk of hip and other non-spine
fractures. For both prevention and treatment, raloxifene is taken daily
as a 60 mg tablet, with or without meals.
Raloxifene appears to decrease the risk of estrogen-dependent breast
cancer by 65 percent over eight years. It is FDA-approved to decrease
the risk of invasive breast cancer in postmenopausal women with
osteoporosis and even in women without osteoporosis who are at high risk
of breast cancer. Raloxifene does not reduce the risk of coronary heart
disease.
Side Effects
Side effects include hot flashes, leg cramps and an increased risk
of deep vein thrombosis (blood clots). Other side effects include
swelling and temporary flu-like symptoms. Raloxifene is not associated
with diseases of the uterus or ovaries and does not affect cognitive
(mental) function.
Raloxifene should not be taken by women at increased risk for
stroke. This includes women who have had previous strokes, transient
ischemic attacks (TIAs), atrial fibrillation (a type of serious
irregular heart beat) or uncontrolled hypertension (high blood
pressure).
The Wall